Domů › Steatotické onemocnění jater › Texas › Austin
Klinické studie Steatotické onemocnění jater v Austin, TX
13 studií pro Steatotické onemocnění jater hledá účastníky v lokalitách v Austin a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
Probíhá náborFáze 3
- GSK Investigational Site, Austin
A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
Probíhá náborFáze 3
- GSK Investigational Site, Austin
A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
Probíhá náborFáze 2
- American Research Corporation, Austin
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Probíhá náborFáze 2
- American Research Corporation, Austin
- Pinnacle Clinical Research - Austin, Austin
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Probíhá náborFáze 3
- IMA Clinical Research Austin, Austin
- American Research Corporation, Austin
- Pinnacle Clinical Research, Austin
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Probíhá náborFáze 3
- Akero Clinical Study Site, Austin
- Akero Clinical Study Site, Austin
- Akero Clinical Study Site, Austin
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Probíhá náborFáze 3
- GSK Investigational Site, Austin
- GSK Investigational Site, Austin
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Probíhá náborFáze 2
- Pinnacle Clinical Research, Austin
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Probíhá náborFáze 3
- 89bio Clinical Study Site, Austin
- 89bio Clinical Study Site, Austin
- 89bio Clinical Study Site, Austin
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Probíhá náborFáze 3
- 89bio Clinical Study Site, Austin
- 89bio Clinical Study Site, Austin
- 89bio Clinical Study Site, Austin
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
Probíhá náborFáze 2
- GSK Investigational Site, Austin
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Probíhá náborFáze 3
- GSK Investigational Site, Austin
- GSK Investigational Site, Austin
- GSK Investigational Site, Austin
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
Probíhá náborFáze 2
- GSK Investigational Site, Austin
- GSK Investigational Site, Austin
- GSK Investigational Site, Austin
Studie Steatotické onemocnění jater v jiných městech
- San Antonio, TX17 studií
- New York City, NY16 studií
- Miami, FL16 studií
- San Diego, CA14 studií
- Houston, TX13 studií
- Richmond, VA12 studií
- Chandler, AZ10 studií
- Tucson, AZ10 studií
- Orlando, FL9 studií
- Hialeah, FL9 studií
- St. Louis, MO9 studií
- Dallas, TX9 studií
Další studie v Austin
- Nemalobuněčný plicní karcinom30 studií
- Rakovina (všechny typy)20 studií
- Obesity20 studií
- Metastatický karcinom19 studií
- Kolorektální karcinom19 studií
- Srdeční selhání18 studií
- Rakovina prsu18 studií
- Nadváha18 studií
- Rakovina vaječníků17 studií
- Rakovina endometria15 studií
- Rakovina prostaty15 studií
- Deprese14 studií
Zdroj: ClinicalTrials.gov, data načtena 5. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.